| scholarly article | Q13442814 |
| P50 | author | Johann Steiner | Q42319648 |
| P2093 | author name string | Bernhard Bogerts | |
| Siegfried Ansorge | |||
| Uwe Lendeckel | |||
| Alicja Bukowska | |||
| Hans-Gert Bernstein | |||
| Henrik Dobrowolny | |||
| Renate Stauch | |||
| Kurt Trübner | |||
| Theresia Ernst | |||
| P2860 | cites work | Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele | Q24684471 |
| Regional and cellular distribution of neural visinin-like protein immunoreactivities (VILIP-1 and VILIP-3) in human brain | Q28138174 | ||
| Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme | Q28254283 | ||
| The insulysin (insulin degrading enzyme) enigma | Q28261817 | ||
| Immunohistochemical and in situ analysis of amyloid precursor-like protein-1 and amyloid precursor-like protein-2 expression in Alzheimer disease and aged control brains | Q28281534 | ||
| Decreased catalytic activity of the insulin-degrading enzyme in chromosome 10-linked Alzheimer disease families | Q28284636 | ||
| Insulin degrading enzyme is expressed in the human cerebrovascular endothelium and in cultured human cerebrovascular endothelial cells | Q33208160 | ||
| Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease. | Q34400472 | ||
| A reduced number of cortical neurons show increased Caldendrin protein levels in chronic schizophrenia | Q34667313 | ||
| Macromolecules involved in production and metabolism of beta-amyloid at the brain barriers | Q35946613 | ||
| Dysregulation of the hypothalamic-pituitary-gonadal axis with menopause and andropause promotes neurodegenerative senescence | Q36063538 | ||
| Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis. | Q36363015 | ||
| Molecular connexions between dementia and diabetes. | Q36837972 | ||
| Shifts in metabolic parameters surrounding glucose homoeostasis resulting from tricyclic antidepressant therapy: implications of insulin resistance? | Q40182599 | ||
| Identification of gamma-endorphin-generating enzyme as insulin-degrading enzyme | Q41151622 | ||
| Lack of neuronal NOS has consequences for the expression of POMC and POMC-derived peptides in the mouse pituitary | Q43793830 | ||
| Insulin receptors in the pituitary gland: morphological evidence for influence on opioid peptide-synthesizing cells | Q44345620 | ||
| Insulin-degrading enzyme in the Alzheimer's disease brain: prominent localization in neurons and senile plaques | Q48230458 | ||
| Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease | Q48404181 | ||
| Plaque-associated overexpression of insulin-degrading enzyme in the cerebral cortex of aged transgenic tg2576 mice with Alzheimer pathology | Q48404243 | ||
| Regional specificity in the neuropathologic substrates of schizophrenia: a morphometric analysis of Broca's area 44 and area 9. | Q48413933 | ||
| Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics | Q48522635 | ||
| Density of Sgt1-immunopositive neurons is decreased in the cerebral cortex of Alzheimer's disease brain | Q48541135 | ||
| Increased number of nitric oxide synthase immunoreactive Purkinje cells and dentate nucleus neurons in schizophrenia | Q48548523 | ||
| Insulin receptor deficits in schizophrenia and in cellular and animal models of insulin receptor dysfunction | Q48596589 | ||
| Atrial natriuretic peptide (ANP) is a high-affinity substrate for rat insulin-degrading enzyme | Q48611951 | ||
| Insulin- and glucagonlike peptides in the brain | Q48749412 | ||
| The amyloid-beta precursor-like protein APLP2 and its relative APP are differentially regulated during neuroendocrine cell activation | Q48773295 | ||
| Degradation of Alzheimer's beta-amyloid protein by human and rat brain peptidases: involvement of insulin-degrading enzyme | Q48812317 | ||
| Desensitization of the neuronal insulin receptor: a new approach in the etiopathogenesis of late-onset sporadic dementia of the Alzheimer type (SDAT)? | Q53264266 | ||
| Effects of chronic treatment with haloperidol and bromocriptine on the processing of beta-endorphin to gamma- and alpha-endorphin in discrete regions of the rat pituitary gland and brain | Q67654313 | ||
| Degradation of insulin-like growth factors I and II by a human insulin degrading enzyme | Q70395087 | ||
| 44 Insulysin and pitrilysin: Insulin-degrading enzymes of mammals and bacteria | Q72059284 | ||
| Identification and isolation of a cytosolic proteolytic complex containing insulin degrading enzyme and the multicatalytic proteinase | Q72102224 | ||
| Non-covalent interaction of ubiquitin with insulin-degrading enzyme | Q73633793 | ||
| Reduced sarcoplasmic reticulum Ca(2+)-uptake and expression of phospholamban in left ventricular myocardium of dogs with heart failure | Q77994741 | ||
| Insulin-degrading enzyme in brain microvessels: proteolysis of amyloid {beta} vasculotropic variants and reduced activity in cerebral amyloid angiopathy | Q80872424 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | brain | Q1073 |
| Insulin degrading enzyme | Q1225690 | ||
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 216-224 | |
| P577 | publication date | 2007-12-14 | |
| P1433 | published in | Journal of Chemical Neuroanatomy | Q15766107 |
| P1476 | title | Regional and cellular distribution patterns of insulin-degrading enzyme in the adult human brain and pituitary | |
| P478 | volume | 35 |
| Q37303380 | Acyl peptide hydrolase degrades monomeric and oligomeric amyloid-beta peptide. |
| Q90701915 | Autoimmune antibodies correlate with immune checkpoint therapy-induced toxicities |
| Q42563794 | Chronic airway-induced allergy in mice modifies gene expression in the brain toward insulin resistance and inflammatory responses. |
| Q26866392 | Insulin in the brain: its pathophysiological implications for States related with central insulin resistance, type 2 diabetes and Alzheimer's disease |
| Q26741609 | Mechanisms of Aβ Clearance and Degradation by Glial Cells |
| Q92384162 | Oxidative inactivation of amyloid beta-degrading proteases by cholesterol-enhanced mitochondrial stress |
| Q55383585 | Proteomic Analysis of Hippocampus and Cortex in Streptozotocin-Induced Diabetic Model Mice Showing Dementia. |
| Q35027962 | Vascular and extravascular distribution of the ATP-binding cassette transporters ABCB1 and ABCC1 in aged human brain and pituitary. |
Search more.